{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:14:47Z","timestamp":1791832487393,"version":"4.3.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/inf.0b013e31829aa63b","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:35:18Z","timestamp":1369157718000},"page":"1096-1101","source":"Crossref","is-referenced-by-count":38,"title":["A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H\u2013Binding Proteins and Implications for Vaccine Coverage in Different Age Groups"],"prefix":"10.1097","volume":"32","author":[{"given":"Susan K.","family":"Hoiseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hellenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala-Eddine","family":"Deghmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Musilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard W.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210202","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues.","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"key":"R2-17-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"R3-17-20210202","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/171.6.1481","article-title":"Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides.","volume":"171","author":"Hayrinen","year":"1995","journal-title":"J Infect Dis"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(11)70027-5","article-title":"From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.","volume":"11","author":"Caron","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"suppl 2","key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0264-410X(00)00047-5","article-title":"Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.","volume":"18","author":"Martin","year":"2000","journal-title":"Vaccine"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2004.11.029","article-title":"Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children.","volume":"23","author":"Findlow","year":"2005","journal-title":"Vaccine"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/hv.23607","article-title":"Human vaccines and immunotherapeutics: news.","volume":"9","author":"Riedmann","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/erv.11.50","article-title":"New frontiers in meningococcal vaccines.","volume":"10","author":"Anderson","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"2001 Study Investigators. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"key":"R13-17-20210202","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis.","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","article-title":"Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.","volume":"77","author":"Seib","year":"2009","journal-title":"Infect Immun"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1093\/nar\/gkp634","article-title":"Detecting species-site dependencies in large multiple sequence alignments.","volume":"37","author":"Schwarz","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R16-17-20210202","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"issue":"Pt 9","key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","article-title":"The modular architecture of meningococcal factor H-binding protein.","volume":"155","author":"Beernink","year":"2009","journal-title":"Microbiology"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870.","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"R20-17-20210202","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/j.vaccine.2012.07.065","article-title":"A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial.","volume":"30","author":"Richmond","year":"2012","journal-title":"Vaccine"},{"key":"R23-17-20210202","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/INF.0b013e31826327e4","article-title":"Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial.","volume":"31","author":"Marshall","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R24-17-20210202","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4161\/hv.19983","article-title":"A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.","volume":"8","author":"Sheldon","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R25-17-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection-serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R28-17-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0950268806007151","article-title":"Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003.","volume":"135","author":"Schrauder","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R29-17-20210202","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: Scalable analysis of bacterial genome variation at the population level.","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"R30-17-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R31-17-20210202","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"R32-17-20210202","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1093\/nar\/gkg500","article-title":"Multiple sequence alignment with the Clustal series of programs.","volume":"31","author":"Chenna","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"R33-17-20210202","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"R34-17-20210202","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.","volume":"6","author":"Lewis","year":"2010","journal-title":"PLoS Pathog"},{"key":"R35-17-20210202","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis.","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"Pt 8","key":"R36-17-20210202","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1099\/00221287-147-8-2321","article-title":"Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp.","volume":"147","author":"Snyder","year":"2001","journal-title":"Microbiology"},{"key":"R37-17-20210202","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.","volume":"18","author":"Lucidarme","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"suppl","key":"R38-17-20210202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/hv.7.0.14564","article-title":"Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease.","volume":"7","author":"Harris","year":"2011","journal-title":"Hum Vaccin"},{"key":"R39-17-20210202","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.vaccine.2009.12.082","article-title":"Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection.","volume":"28","author":"Seib","year":"2010","journal-title":"Vaccine"},{"key":"R40-17-20210202","doi-asserted-by":"crossref","first-page":"e33016","DOI":"10.1371\/journal.pone.0033016","article-title":"Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.","volume":"7","author":"de Filippis","year":"2012","journal-title":"PLoS One"},{"key":"R41-17-20210202","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2010.11.072","article-title":"Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.","volume":"29","author":"Mothibeli","year":"2011","journal-title":"Vaccine"},{"key":"R42-17-20210202","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R43-17-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"R44-17-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"R45-17-20210202","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.vaccine.2011.06.025","article-title":"Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.","volume":"29","author":"Marsh","year":"2011","journal-title":"Vaccine"},{"key":"R46-17-20210202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/hv.23222","article-title":"Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.","volume":"9","author":"Anderson","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R47-17-20210202","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J Clin Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31829aa63b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T21:15:07Z","timestamp":1688246107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201310000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31829aa63b","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}